The global market for Postoperative Pain Management experienced significant growth in 2021 and is expected to continue to expand rapidly over the forecast period. The rise in trauma incidences worldwide requiring postoperative management is a major factor driving revenue growth in the market. Postoperative pain management is crucial for a quick recovery and to prevent complications such as pneumonia and blood clots. Types of pain that can occur post-operation include muscle pain, throat pain, and movement pain.

The market is experiencing growth driven by multiple factors, such as the heightened need for postoperative pain management stemming from an uptick in trauma cases and road accidents necessitating surgical intervention. Furthermore, there is a growing number of elderly and pediatric patients undergoing surgical procedures, along with an increase in surgical interventions for chronic illnesses like cancer. Additionally, the market is benefiting from the growing demand for non-opioid analgesics to manage postoperative pain and the expanding scope of clinical research dedicated to drug development for pain management.

Get a free sample PDF of the report, visit @

https://www.reportsanddata.com/download-free-sample/5845

However, lack of patient awareness about postoperative complications is a major factor restraining revenue growth of the postoperative pain management market. On the other hand, technological advancements in the drug development of pain management, improved healthcare facilities with the rise in research and development for postoperative pain management, and government initiatives in spreading awareness about postoperative complications and pain management post-operation are presenting lucrative growth opportunities.

Key Players in the Postoperative Pain Management Market –

• Teva Pharmaceutical Industries Ltd.
• Purdue Pharma L.P
• Johnson & Johnson
• Endo International plc
• Pacira Pharmaceuticals, Inc.
• Bayer AG
• Durect Corporation
• Eli Lilly and Company
• Abbott
• Novartis AG
• Hoffmann-La Roche Ltd
• Pfizer Inc.
• Merck & Co., Inc.
• GlaxoSmithKline Plc

North America emerged as the largest market for postoperative pain management, with the highest revenue share, attributed to rising healthcare expenditure, increasing awareness, and rising incidences of trauma and accidents in this region. Asia Pacific is expected to register the fastest revenue growth rate over the forecast period, mainly due to the rising number of patients with surgical treatment for various chronic diseases, government initiatives to promote awareness, and the rising demand for the treatment.

The report provides historical data points, forecast, and revenue growth at a global, regional, and country level, and provides analysis, industry trends, and consumption pattern details for each region, major country, and segment from 2019-2030. The global market report includes industry trends, drivers, restraints, opportunities, threats, market strategies, segment revenue, and revenue share contribution by each regional and country market. It also offers industry analysis and competitive landscape, company financials, and impact analysis.

Notable Innovations in the Postoperative Pain Management Market –

The postoperative pain management market has seen several notable innovations in recent years. Here are some of the significant innovations in the market:

1. BioElectronics Corporation's RecoveryRX Device: In August 2019, BioElectronics Corporation announced that the US FDA had approved the RecoveryRX device for its use in postoperative pain management. The device is a wearable neuromodulation device that uses low-frequency electrical pulses to reduce pain and inflammation.
2. Alembic Pharmaceuticals' Pregabalin Capsules: In July 2019, Alembic Pharmaceuticals announced that the US FDA had approved pregabalin capsules for neuropathic pain. Pregabalin is a medication that works by reducing the number of pain signals sent by damaged nerves.
3. Dinalbuphine Sebacate for Arthroscopic Shoulder Surgery: The Tri-Service General Hospital in Taipei city, Taiwan, is conducting a phase 4 clinical study on postoperative pain management with extended-release Dinalbuphine Sebacate in patients undergoing arthroscopic shoulder surgery. Dinalbuphine Sebacate is a new opioid analgesic that has shown promising results in clinical trials.
4. Non-Opioid Analgesics: The rising demand for non-opioid analgesics for postoperative pain management has driven innovation in this area. Non-opioid analgesics, such as acetaminophen and ibuprofen, are becoming increasingly popular for the management of postoperative pain.
5. Technological Advancements in Drug Development: Technological advancements in the drug development of pain management have led to the development of new and more effective pain medications. For example, the use of nanotechnology in drug delivery systems has improved the effectiveness of pain medication.

The market is segmented based on type, treatment, product type, dosage forms, route of administration, age, gender, end-user, prescription type, and distribution channel. The types of pain that the market caters to include neuropathic pain and nociceptive pain, and the treatment options include opioid analgesics, non-opioid analgesics, non-steroidal anti-inflammatory drugs, local anesthetic, and others. The product types available in the market include tablets, creams, ointments, and injectables. The market is also segmented based on the age and gender of the patient, and the end-user includes hospital pharmacy, online pharmacy, and retail pharmacy. The prescription type includes over-the-counter (OTC) drugs and prescription (Rx) drugs, and the distribution channels include offline and online.

Request a customized copy of the report @

https://www.reportsanddata.com/request-customization-form/5845

Thank you for reading our report. To inquire about customization or any query about the report, please get in touch with us. Our team will make sure the report is best suited to your needs.  

Browse for more reports:

Dermatome Devices Market

Diabetic Foot Ulcers Treatment Market

Deoxyribonucleic Acid (DNA) Testing Market

Doppler Ultrasound System Market

Infection Prevention Devices Market

About Reports and Data 

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behaviour shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

John W

(Head of Business Development)

Reports and Data | Web: www.reportsanddata.com

Direct Line: +1-212-710-1370

E-mail: sales@reportsanddata.com

Blogs | Press Release | Industry News | Our competencies

Browse More Upcoming Reports @ https://www.reportsanddata.com/upcoming-reports

Browse More Latest Reports @ https://www.reportsanddata.com/report